SREBF2 and neoplasm: The nuclear colocalized SOX18 and SREBP2 in proliferating-phase IH and regrowing IH suggest that SOX18+SREBP2+ endothelial nuclei may serve as a biomarker for the vasculogenic capacity of the tumor.